Lumenis Be., a leading energy-based medical device company for aesthetic and eye care applications announced the launch of OptiPLUS, the first dual frequency radiofrequency (RF) device on the market. It delivers heat across different tissue layers, increasing blood circulation to promote medical performance and aesthetic results.1 OptiPLUS is a complementary device to Lumenis’ novel OptiLIGHT technology, which targets the root cause of dry eye disease.
While OptiLIGHT relies on a pioneering light-based technology to break the vicious cycle of dry-eye inflammation due to meibomian gland dysfunction, OptiPLUS is a dedicated device that employs a breakthrough RF energy to enhance clinical results. The FDA-cleared dual-frequency RF technology enables energy penetration to different skin depths, heating the superficial layer to promote collagen formation and stimulate peri-orbital skin rejuvenation while also reaching into the deeper tissue to target the meibomian glands.1,2,3
A unique monopolar electrode ensures optimized contact with the delicate contours in the peri-orbital area, enabling OptiPLUS to offer unmatched safety and unrivaled patient comfort.4 Used to treat patients across a range of skin types, OptiPLUS leverages the benefits of state-of-the-art technology with clinically validated, pre-embedded settings and temperature control for better efficacy and safety.
“I’m very pleased with the clinical outcomes experienced while using OptiLIGHT to treat dry eye disease, and I’m excited about incorporating OptiPLUS as an essential addition to my armamentarium,” said James Chelnis, MD, FACS, an ophthalmologist at Manhattan Face & Eye. “As the leading investigator in a recently published clinical study, I discovered that the pairing of these two technologies brings remarkable results, significantly improving the number of expressible meibomian glands (over 150% average), meibum clarity (over 70%) and symptoms (over 60%)3. The fact that it also offers aesthetic benefits is just another great advantage.”
Itay Mayer, Managing Director of Lumenis Vision said, “Lumenis has a relentless commitment to innovation and eye care advancement. We’ve driven substantial progress in the space with our gold standard OptiLIGHT device and now with our unique dual frequency RF technology, OptiPLUS.” Mayer continued, “Our passion for researching and developing groundbreaking solutions allows eye care practitioners to provide the highest level of care. We are also proud to partner with customers to offer marketing and clinical support that is unparalleled in our industry. In all we do, we focus on what matters the most — making a meaningful impact by transforming people’s lives.”
